Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Cortical excitability changes over time in progressive multiple sclerosis.
Blood-brain barrier permeability of normal appearing white matter in relapsing-remitting multiple sclerosis.
Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis.
Evaluation of clinical interest of anti-aquaporin-4 autoantibody followup in neuromyelitis optica.
Impaired regulatory function and enhanced intrathecal activation of B cells in neuromyelitis optica: distinct from multiple sclerosis.
Preventive and Therapeutic Effects of Adenanthin on Experimental Autoimmune Encephalomyelitis by Inhibiting NF-κB Signaling.
Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis.
Neuromyelitis optica in child: diagnostic and therapeutic challenges.
Fibrinogen: A Circulating Factor in Search for Its Genetic Architecture.
Quantification of Th1 and Th17 Cells with Intracellular Staining Following PMA/Ionomycin Stimulation.
Peripheral nerve proteins as potential autoantigens in acute and chronic inflammatory demyelinating polyneuropathies.
Perivenular brain lesions in a primate multiple sclerosis model at 7-tesla magnetic resonance imaging.
Second generation S1P pathway modulators: Research strategies and clinical developments.
The neural androgen receptor: a therapeutic target for myelin repair in chronic demyelination.
The blood-brain barrier-permeable catechol-O-methyltransferase inhibitor dinitrocatechol suppresses experimental autoimmune encephalomyelitis.
Antibody response against gastrointestinal antigens in demyelinating diseases of the central nervous system.
Amyloid PET imaging in multiple sclerosis: an (18)F-florbetaben study.
Is It Too Early to Predict the Failure of Natalizumab in NMO?
Gait and six-minute walk performance in persons with multiple sclerosis.
Cerebrovascular hemodynamic changes in multiple sclerosis patients during head-up tilt table test: effect of high-dose intravenous steroid treatment.
Surgery and risk for multiple sclerosis: a systematic review and meta-analysis of case-control studies.
Sample size estimation for negative binomial regression comparing rates of recurrent events with unequal follow-up time.
Quality of life reporting in multiple sclerosis clinical trials: enough quality?
Silencing of Abcc8 or inhibition of newly upregulated Sur1-Trpm4 reduce inflammation and disease progression in experimental autoimmune encephalomyelitis.
Changes in Gross Grasp Strength and Fine Motor Skills in Adolescents with Pediatric Multiple Sclerosis.
Pages
« first
‹ previous
…
302
303
304
305
306
307
308
309
310
…
next ›
last »